UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 105

Sortiert nach

Small Molecule Inhibitors Targeting the Achilles' Heel of Androgen Receptor Activity

Cancer research (Chicago, Ill.), 2011-02, Vol.71 (4), p.1208-1213

SADAR, Marianne D

2011

Volltextzugriff (PDF)

Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic

International journal of urology, 2016-08, Vol.23 (8), p.654-665

2016

Volltextzugriff (PDF)

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer

Frontiers in endocrinology (Lausanne), 2017-01, Vol.8, p.2-2

2017

Volltextzugriff (PDF)

Treatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer

International journal of molecular sciences, 2024-02, Vol.25 (3), p.1817

2024

Volltextzugriff (PDF)

An androgen receptor N-terminal domain antagonist for treating prostate cancer

The Journal of clinical investigation, 2013-07, Vol.123 (7), p.2948-2960

2013

Volltextzugriff (PDF)

Targeting the N‐Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer

The oncologist (Dayton, Ohio), 2016-12, Vol.21 (12), p.1427-1435

2016

Volltextzugriff (PDF)

Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor

Cancer cell, 2010-06, Vol.17 (6), p.535-546

2010

Volltextzugriff (PDF)

Combination therapy with androgen receptor N‐terminal domain antagonist EPI‐7170 and enzalutamide yields synergistic activity in AR‐V7‐positive prostate cancer

Molecular oncology, 2020-10, Vol.14 (10), p.2455-2470

2020

Volltextzugriff (PDF)

Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer

Clinical cancer research, 2016-06, Vol.22 (11), p.2744-2754

2016

Volltextzugriff (PDF)

Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor

Expert opinion on drug discovery, 2020-05, Vol.15 (5), p.551-560

Sadar, Marianne D.

2020

Volltextzugriff (PDF)

Isolation and characterization of castration-resistant prostate cancer LNCaP95 clones

Human cell : official journal of Human Cell Research Society, 2021-01, Vol.34 (1), p.211-218

2021

Volltextzugriff (PDF)

Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer

World journal of urology, 2012-06, Vol.30 (3), p.311-318

Sadar, Marianne D.

2012

Volltextzugriff (PDF)

Activation of the Androgen Receptor N-terminal Domain by Interleukin-6 via MAPK and STAT3 Signal Transduction Pathways

The Journal of biological chemistry, 2002-03, Vol.277 (9), p.7076-7085

2002

Volltextzugriff (PDF)

Drugging the Undruggable: Targeting the N-Terminal Domain of Nuclear Hormone Receptors

Advances in experimental medicine and biology, 2022, Vol.1390, p.311-326

2022

Volltextzugriff (PDF)

N-terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy

Molecular oncology, 2015-03, Vol.9 (3), p.628-639

2015

Volltextzugriff (PDF)

LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer

BMC genomics, 2010-09, Vol.3 (1), p.43-43

2010

Volltextzugriff (PDF)

Identification of novel androgen-responsive genes by sequencing of LongSAGE libraries

BMC genomics, 2009-10, Vol.10 (1), p.476-476, Article 476

2009

Volltextzugriff (PDF)

Ligand-independent Activation of the Androgen Receptor by Interleukin-6 and the Role of Steroid Receptor Coactivator-1 in Prostate Cancer Cells

The Journal of biological chemistry, 2002-10, Vol.277 (41), p.38087-38094

2002

Volltextzugriff (PDF)

Differential Gene Expression Profiles between N-Terminal Domain and Ligand-Binding Domain Inhibitors of Androgen Receptor Reveal Ralaniten Induction of Metallothionein by a Mechanism Dependent on MTF1

Cancers, 2022-01, Vol.14 (2), p.386

2022

Volltextzugriff (PDF)

FUS/TLS is a co-activator of androgen receptor in prostate cancer cells

PloS one, 2011-09, Vol.6 (9), p.e24197

2011

Volltextzugriff (PDF)

Niphatenones, Glycerol Ethers from the Sponge Niphates digitalis Block Androgen Receptor Transcriptional Activity in Prostate Cancer Cells: Structure Elucidation, Synthesis, and Biological Activity

Journal of medicinal chemistry, 2012-01, Vol.55 (1), p.503-514

2012

Volltextzugriff (PDF)

Characterization of niphatenones that inhibit androgen receptor N-terminal domain

PloS one, 2014, Vol.9 (9), p.e107991

2014

Volltextzugriff (PDF)

Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer

PloS one, 2017-03, Vol.12 (3), p.e0174134-e0174134

2017

Volltextzugriff (PDF)

Androgen receptor and its splice variants in prostate cancer

Cellular and molecular life sciences : CMLS, 2011-12, Vol.68 (24), p.3971-3981

2011

Volltextzugriff (PDF)

Connective Tissue-Activating Peptide III: A Novel Blood Biomarker for Early Lung Cancer Detection

Journal of clinical oncology, 2009-06, Vol.27 (17), p.2787-2792

2009

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(94)

Publikationsform

Artikel
(103)
Buchkapitel
(2)

Sprache

Englisch
(105)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Small Molecule Inhibitors Targeting the Achilles' Heel of Androgen Receptor Activity

Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer

Treatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer

An androgen receptor N-terminal domain antagonist for treating prostate cancer

Targeting the N‐Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer

Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor

Combination therapy with androgen receptor N‐terminal domain antagonist EPI‐7170 and enzalutamide yields synergistic activity in AR‐V7‐positive prostate cancer

Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer

Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor

Isolation and characterization of castration-resistant prostate cancer LNCaP95 clones

Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer

Activation of the Androgen Receptor N-terminal Domain by Interleukin-6 via MAPK and STAT3 Signal Transduction Pathways

Drugging the Undruggable: Targeting the N-Terminal Domain of Nuclear Hormone Receptors

N-terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy

LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer

Identification of novel androgen-responsive genes by sequencing of LongSAGE libraries

Ligand-independent Activation of the Androgen Receptor by Interleukin-6 and the Role of Steroid Receptor Coactivator-1 in Prostate Cancer Cells

Differential Gene Expression Profiles between N-Terminal Domain and Ligand-Binding Domain Inhibitors of Androgen Receptor Reveal Ralaniten Induction of Metallothionein by a Mechanism Dependent on MTF1

FUS/TLS is a co-activator of androgen receptor in prostate cancer cells

Niphatenones, Glycerol Ethers from the Sponge Niphates digitalis Block Androgen Receptor Transcriptional Activity in Prostate Cancer Cells: Structure Elucidation, Synthesis, and Biological Activity

Characterization of niphatenones that inhibit androgen receptor N-terminal domain

Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer

Androgen receptor and its splice variants in prostate cancer

Connective Tissue-Activating Peptide III: A Novel Blood Biomarker for Early Lung Cancer Detection

Suchergebnisse filtern